Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
30. August 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9055
Articles 1 - 20 / 181088
Prognostic significance of systemic immunoinflammatory biomarkers and pathological features in clear cell renal cell carcinoma: a multicenter study.
Ann Med
Yu Z, Yang J, Lv X, Zhang J, Chen D.
PMID: 42669053 [PubMed - indexed for MEDLINE]
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial.
JAMA Intern Med
Leong DP, Higano C, Cano Garcia C, Fradet V, Siemens DR, Niazi T, Shayegan B, Guha A, Cirne F, Selvanayagam JB, Violette PD, Valle FH, Lavallée LT, Duceppe E, Anderson P, Xavier D, Lopez-Lopez JP, Villareal Trujillo N, Galapo Kann A, Piccoli RK, Mourtzakis M, Sarid D, Narasimha S, Luke PPW, Hajjar LA, Lukka H, Klotz L, Balasubramanian K, Mian R, Agapay S, Rangarajan S, Karampatos S, Ng KKH, Avezum A, Devereaux PJ, Pinthus JH, RADICAL PC Investigators.
PMID: 42669035 [PubMed - as supplied by publisher]
Clinico-genomic risk stratification for biomarker-enriched trial design in poor-prognosis metastatic castrate-resistant prostate cancer (mCRPC).
J Liq Biopsy
Kohli M, Wang L, Tan AC, Fadlullah MZ, Shankar A, Mandrekar SJ, Haaland B.
PMID: 42668516 [PubMed]
Comparative assessment of METastasis Reporting and Data System for Prostate Cancer versus Prostate Cancer Clinical Trials Working Group 3 Criteria in assessing treatment response in patients with metastatic castration-resistant prostate cancer.
Eur Urol Open Sci
Russo L, Longoria O, Bottazzi S, Porta N, Biscombe K, Withey SJ, Avesani G, Abramovicz K, Blackledge MD, D'Erme L, Russell-Rose K, Taha T, Sharp A, Paschalis A, Sala E, Koh DM, de Bono J, Tunariu N.
PMID: 42668444 [PubMed]
Prospective validation of a urine-based proteomics test for predicting clinically significant prostate cancer in biopsy-naïve patients.
Br J Cancer
Morillo AC, Jobre KN, Lendinez Cano G, Blanca-Pedregosa A, Lopez Ruiz D, Parada J, Heidegger I, Culig Z, Lopez-Beltran A, Carrasco-Valiente J, Mischak H, Medina RA, Campos Hernandez JP, Frantzi M, Gómez Gómez E.
PMID: 42668309 [PubMed - as supplied by publisher]
Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial.
Eur Urol Focus
Zuur LG, de Barros HA, Ottens VA, Berrens AC, van Oosterom MN, Donswijk ML, Hendrikx JJMA, van Leeuwen FWB, van der Poel HG, van Leeuwen PJ.
PMID: 42668258 [PubMed - as supplied by publisher]
Emerging frontiers and challenges of artificial intelligence in PSMA-PET imaging: pioneering a new chapter in prostate cancer care.
Jpn J Radiol
Wang Y, Cheng C, Huang B, Zuo C.
PMID: 42667563 [PubMed - as supplied by publisher]
Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer.
Hum Genet
Vlaming M, Kiemeney LALM, Koole W, van Oort IM, Bleiker EMA, Ausems MGEM, Frederix GWJ.
PMID: 42667419 [PubMed - indexed for MEDLINE]
Safety and preliminary efficacy results of a new micellar formulation of docetaxel in patients with metastatic castration-resistant prostate cancer - SAKK 67/20 trial.
Cancer Chemother Pharmacol
Colombo I, Rietveld PCS, Fischer S, Merlo S, Vogl U, Cathomas R, Koolen SLW, Zoelly D, Gobat K, Micheloud C, Eckhardt K, Sessa C, Stathis A, Omlin A, Joerger M.
PMID: 42667368 [PubMed - indexed for MEDLINE]
Using human proteomic and lipidomic to exploration drug target of bladder cancer.
World J Urol
Cao Q, Liu H, Xu Y, Wang Y, An L, Li J, Ren H, Zhou D, Liang J, Guan Z, Wang W, Wu C, Yang Y, Wang J, Jiang N.
PMID: 42667367 [PubMed - indexed for MEDLINE]
Perioperative treatment for muscle invasive bladder cancer in the era of immunotherapy.
Ther Adv Urol
Williams C, Shah Y, Xia L.
PMID: 42666617 [PubMed]
Prognostic value of preoperative systemic immune-inflammation index in patients with bladder cancer undergoing radical cystectomy: a systematic review and meta-analysis.
Front Oncol
Zhao M, Wu Y, Luo B, Long J, Luo J, Liu R, Zhang H, He B.
PMID: 42666146 [PubMed]
Alkaline Phosphatase and Prostate-specific Antigen Response in Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide Alone or in Combination with Radium-223: Ad Hoc Analysis of the PEACE-3 Consortium Trial.
Eur Urol Oncol
Soares A, Gillessen S, Choudhury A, Saad F, Gallardo E, Loriot Y, McDermott RS, Rodriguez-Vida A, Velho PI, Nolè F, Cruz FM, Roumeguère TA, Daugaard G, Yamamura R, Poncet C, Coens C, Fournier B, Tombal BF.
PMID: 42665513 [PubMed - as supplied by publisher]
Re: Paolo Gontero, Richard Perry, Daisy Bridge, et al. Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus. Eur Urol Oncol 2026;9:652-9.
Eur Urol Oncol
Scarpa RM.
PMID: 42665512 [PubMed - as supplied by publisher]
Perioperative and Oncological Outcomes of Robot-assisted Versus Open Radical Cystectomy: A Propensity Score-matched Multicenter Study from Japan.
In Vivo
Yamashita S, Yasuhara M, Higuchi M, Iwagami S, Wakamiya T, Matsumura N, Nishihata M, Kohjimoto Y.
PMID: 42665393 [PubMed - indexed for MEDLINE]
Inflammatory Myofibroblastic Tumor of the Urinary Bladder Presenting as a Radiological cT3 Mass: A Case Report and Narrative Review of 89 Cases.
In Vivo
Chen HX, Liu SL, Huang CP, Hsu YC, Chiu HC.
PMID: 42665386 [PubMed - indexed for MEDLINE]
Real-world Feasibility of Adjuvant Nivolumab for High-risk Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
In Vivo
Yanishi M, Matsushita J, Kita A, Mishima T, Kinoshita H.
PMID: 42665381 [PubMed - indexed for MEDLINE]
Impact of PI-RADS During Active Surveillance for Prostate Cancer on Pathological Findings at Repeat Biopsy.
In Vivo
Tohi Y, Tanaka K, Kato T, Fujiwara K, Kaji A, Harada S, Kohashiguchi K, Abe Y, Naito H, Okazoe H, Taoka R, Ueda N, Nishiyama Y, Sugimoto M.
PMID: 42665380 [PubMed - indexed for MEDLINE]
Radiotherapy With Hyperthermia for Prostatic Ductal Adenocarcinoma: Primary and Salvage Cases.
In Vivo
Matsuura Y, Nakaya D, Tani S, Shimajiri S, Fujimoto N, Ohguri T.
PMID: 42665379 [PubMed - indexed for MEDLINE]
Metastatic Renal Cell Carcinoma to the Calcaneus and Talus Presenting as Plantar Fasciitis: A Case Study and Review of the Literature.
Foot Ankle Spec
Abdul Rahman HQ, Atwater LC.
PMID: 42665295 [PubMed - as supplied by publisher]
Articles 1 - 20 / 181088
Page 1 of 9055
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy